Navigation Links
Vical's Vaxfectin Adjuvant Achieves Dose-Sparing Effect With,Seasonal Influenza Vaccine

Vaxfectin(TM) may have potential applications as an adjuvant for other protein-based vaccines as well. The company holds patents in the United States covering Vaxfectin(TM) and its use with conventional vaccines against infectious diseases and cancer, and in both the United States and Europe covering the use of Vaxfectin(TM) with DNA vaccines.

Vical researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Potential applications of the company's DNA delivery technology include DNA vaccines for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The company is developing certain infectious disease vaccines and cancer therapeutics internally. In addition, the company collaborates with major pharmaceutical companies and biotechnology companies that give it access to complementary technologies or greater resources. These strategic partnerships provide the company with mutually beneficial opportunities to expand its product pipeline and address significant unmet medical needs. Additional information on Vical is available at www.vical.com.

This press release contains forward-looking statements subject to risks and uncertainties that could cause actual results to differ materially from those projected, including: whether Vical or others will continue evaluation of Vaxfectin(TM) as an adjuvant for conventional vaccines against seasonal or pandemic influenza; whether Vaxfectin(TM) will be used as a dose-sparing agent with conventional influenza vaccines against seasonal or pandemic influenza strains; whether Vical or others will continue development of the pandemic influenza DNA vaccine cand
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Vicals Vaxfectin Adjuvant With Needle-free Delivery Enhances DNA Vaccine Performance; Yields Antibody Responses Comparable to Electroporation Without Tolerability Issues
2. Vaxfectin-formulated Measles DNA Vaccine Elicits Long-term Protection and Sterilizing Immunity in Nonhuman Primates
3. New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by Paclitaxel
4. Updated Overall Survival Data From Pivotal Herceptin Adjuvant Studies in HER2-Positive Breast Cancer
5. Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia Clinical Trial
6. Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure Reduction During Important Early Morning Period When Most Adverse Cardiovascular Events Occur
7. Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL)
8. Micromet Achieves Milestone in BiTE Research Collaboration with MedImmune
9. Addex Achieves Statistically Significant Outcome in Phase IIa Clinical Trial With ADX10059 in Gastro-Esophageal Reflux Disease
10. Mymetics HIV Vaccine Achieves Research Breakthrough, Eliciting Protective Antibody Response in Mucosal Tissues of Non-Human Primate Model
11. Integrated Biopharmas Proprietary Vaccine Technology Achieves Strong Positive Results
Post Your Comments:
(Date:6/19/2013)... 19, 2013   NextDocs announced today that ... research organization, at DIA 2013 , the Drug ... present case studies that explore best practices for making ... trial master file (eTMF) systems. Sharon ... alongside Krystyna Kowalczyk , executive vice president of ...
(Date:6/19/2013)... , June 19, 2013  Caradigm today ... a solution designed to help healthcare organizations ... data while supporting their compliance with data ... represents a milestone in the delivery of ... capabilities for health systems. ...
(Date:6/19/2013)... , June 19, 2013   Voices Against ... finding a cure for brain cancer, today announced that ... grant to support the clinical investigation of Toca 511 ... high grade glioma brain cancer (Grade 3 or Grade ... novel treatments for advanced cancer, with an initial focus ...
Breaking Medicine Technology:NextDocs and Novella to Present on eTMF at DIA 2013 2Caradigm Provisioning Helps Healthcare Organizations Improve Clinical Efficiency, Manage Risk 2Caradigm Provisioning Helps Healthcare Organizations Improve Clinical Efficiency, Manage Risk 3Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 2Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 3
... MINNETONKA, Minn., Aug. 25 MedNet Solutions, a ... clinical study management systems, is pleased to announce ... Inc. 5000 list for the fourth year in ... compiled annually by Inc. magazine, recognizes ...
... VIEJO, Calif., Aug. 25 Ambry Genetics, a global ... acquired the Illumina HiSeq 2000 Next Generation Sequencing System ... BeadXpress Genotyping System. Ambry Genetics has been an early ... extensive experience as a Certified Service Provider. A team ...
Cached Medicine Technology:MedNet Solutions Named to the Inc. 5000 List of Fastest Growing Companies for the Fourth Consecutive Year 2Ambry Genetics Announces the Addition of Illumina HiSeq 2000 and First 510(K) Approved BeadXpress® to Its Sequencing and Genotyping Capabilities 2
(Date:6/19/2013)... Texas (PRWEB) June 19, 2013 ... today announced its intent to purchase privately ... Florida, a leader in wheelchair accessible vehicle sales, ... of Auto Mobility Sales, Inc compliments and expands ... wheelchair accessible mobility dealers . The acquisition ...
(Date:6/19/2013)... CA (PRWEB) June 19, 2013 Kleritec, ... its website located at http://www.kleritec.com . In the ... creative, pre-selected, art and activities packages for pre-school and ... products as a method to aid teachers across the ... and engaged in learning. , Included in the art ...
(Date:6/19/2013)... Citi Bike has come to New York City in ... to know for sure how many patients will choose to take ... the option. In fact, he’s happy about anything that might ... it more convenient for them to visit his office at 133 ... Alternative Medicine at Back and Body Medical and an experienced ...
(Date:6/19/2013)... - In a major international study led by researchers ... the targeted therapy ibrutinib continues to show remarkable promise ... lymphoma (MCL). , The most recent interim findings of ... the New England Journal of Medicine . Previous ... 54th American Society of Hematology Annual Meeting and Exposition. ...
(Date:6/19/2013)... Children had half as many emergency department visits ... on five or more days a week, according to ... Children,s Hospital and Johns Hopkins University. , The new ... Journal of Pediatrics and will be presented at ... an important step in understanding where primary care practices ...
Breaking Medicine News(10 mins):Health News:HASCO Medical, Inc. to Acquire Auto Mobility Sales, Inc. 2Health News:Kleritec Announces Addition of Educational Products. 2Health News:New York City's Back and Body Medical Welcomes Citi Bike to Midtown Manhattan 2Health News:New York City's Back and Body Medical Welcomes Citi Bike to Midtown Manhattan 3Health News:Ibrutinib continues strong showing against mantle cell lymphoma 2Health News:Extended primary care office hours might help keep kids out of the emergency department 2
... in heart attack or mortality rates , , SUNDAY, Nov. 4 ... to date, Harvard researchers report that they have found drug-eluting ... than bare metal stents do. , "There has been a ... investigator Dr. Laura Mauri, an assistant professor of medicine at ...
... ... Heart Association,s Scientific Sessions 2007 ... 4 , WHO: Dr. Amir Lerman, Professor of Medicine, Mayo Clinic, Rochester, MN ... Sweden Mr. Israel Schreiber, President ...
... North Carolina team of doctors, nurses, hospitals and emergency ... to provide faster, more effective treatment for heart attack ... fancy new equipment. But it does require competitors to ... move treatment forward empowering emergency services personnel in ...
... props open closed aortas in older patients, research suggests ... high-risk heart patients with narrowed aortas who typically need ... option -- an implanted, balloon-expandable aortic valve. , The ... the problem valve and then inflated, experts said. In ...
... increase in their risk of heart attacks or other ... the largest-ever study of the issue, being presented at ... Scientific Exposition in San Francisco. , Although donors are ... (hypertension) during follow-up, it is unclear whether this represents ...
... Union Election, Note Hospital System Failing ... to Live Up to its Own ... elected officials and other healthcare activists joined hospital,workers from the St. ... Hospital on Saturday, where they called for the health,system,s leadership to ...
Cached Medicine News:Health News:Drug-Coated Stents No Riskier in Long Run Than Bare Metal Ones 2Health News:Drug-Coated Stents No Riskier in Long Run Than Bare Metal Ones 3Health News:How Early Can We Detect Cardiovascular Disease Less Expensively ... Even in Childhood? 2Health News:RACE: a statewide model of better, faster heart attack care 2Health News:RACE: a statewide model of better, faster heart attack care 3Health News:Balloon Valve May Be Alternative to Open-Heart Surgery 2Health News:Balloon Valve May Be Alternative to Open-Heart Surgery 3Health News:No increase in cardiovascular risk for living kidney donors 2Health News:Healthcare Workers, Community Activists Call for Fair Election Agreement at St. Joseph Health System 2
The Fujinon's R410 laparoscope is the first to bring a 410,000 pixel CCD to the end of the scope. Superior imaging and color replication, along with a unique lens washing capability make the R410 the...
The ACMI™ Operative Laparoscopy System is designed for single- and dual-incision CO2 laser procedures and is used with 45cm laparoscopic instruments....
The edge-to-edge clarity of the laparoscopes provides excellent image definition.Even small structures are easily recognized due to the optimal depth of focus. The outstanding optical quality provide...
Stryker bariatric laparoscopes set the standard in picture quality....
Medicine Products: